Johnson & Johnson Development Corporation, the in-house venture arm of the US-based consumer and medical goods maker, has linked up again with venture capital firm De Novo Ventures and joined the second round of financing for Astute Medical, a San Diego-based medical diagnostics company focused on high-risk conditions.

Astute raised $26.5m in series B funding in a round led by VCs Domain Associates and Delphi Ventures. JJDC joined for the first time while De Novo returned having previously invested…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?